Figure 3From: Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedinClinical appearance centrofacial telangiectasia (TAE) in patients treated with bosentan or iloprost after ten months. (a- c) 57-year-old man treated with bosentan; (d- f) 54-year-old woman treated with iloprost.Back to article page